Search Results 51-60 of 9309 for Mediate
The aim of this project is to evaluate whether kidney biopsy tissue will stain positive for C3d under immunofluorescence in patients who had renal thrombotic ...
Immune-mediated adverse events. PD-1/PD-L1 targeted immunotherapy is generally well-tolerated and has fewer acute side effects compared with standard cytotoxic ...
Tumor cell PD-L1 may mediate sensitivity to chemotherapy in colorectal cancer treatment featured image. Cancer. Tumor cell PD-L1 may mediate sensitivity to ...
... mediated rejection (AMR) at Week 52. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...
Mayo Clinic M.D., Ph. · Tumor cell PD-L1 may mediate sensitivity to chemotherapy in colorectal cancer treatment featured image · Mayo Clinic study suggests ...
Tumor cell PD-L1 may mediate sensitivity to chemotherapy in colorectal cancer treatment featured image · Mayo Clinic study suggests patients with lung cancer be ...
The purpose of this study is to provide expanded access of patisiran to patients with transthyretin-mediated amyloidosis (ATTR amyloidosis) with cardiomyopathy.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.